LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Paris:ADOC) (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of ...

INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev ™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's ...

About The Study: In people with inadequately controlled type 2 diabetes treated with basal insulin in this randomized clinical trial with 1,428 participants, weekly tirzepatide compared with prandial ...

Uninsured Americans pay nearly $98 on average for a vial of Eli Lilly's generic insulin. Eli Lilly earlier this year vowed to slash the list price of its generic insulin, Lispro, from $82.42 per vial ...

HAMBURG, Germany -- Adding weekly tirzepatide (Mounjaro) to basal insulin reduced HbA1c in patients with poorly controlled type 2 diabetes compared with adding three-times-daily insulin lispro, the ...

LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC) (Paris:ADOC), a clinical stage biopharmaceutical company focused on diabetes treatment and other metabolic ...

HAMBURG, Germany ― Once-weekly tirzepatide (Mounjaro, Lilly) added to insulin glargine resulted in greater reductions in A1c along with more weight loss and less hypoglycemia compared with prandial ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

U.S. insulin prices substantially increased from 2012 to 2015; however, the introduction of new products has led to substantial discounting practices and lower net prices, according to a study ...

The pharmaceutical Eli Lilly and Company announced Wednesday that it will reduce some insulin prices by 70% and expand access to a program that caps prices at $35 per month. The company says its ...

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...